| 000 | 01705 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516155534.0 | ||
| 264 | 0 | _c20140110 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1473-5571 | ||
| 024 | 7 |
_a10.1097/QAD.0b013e3283612419 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStellbrink, Hans-Jürgen | |
| 245 | 0 | 0 |
_aDolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cJul 2013 |
||
| 300 |
_a1771-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xisolation & purification |
| 650 | 0 | 4 |
_aHeterocyclic Compounds, 3-Ring _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOxazines |
| 650 | 0 | 4 | _aPiperazines |
| 650 | 0 | 4 | _aPyridones |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 | _aSingle-Blind Method |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aReynes, Jacques | |
| 700 | 1 | _aLazzarin, Adriano | |
| 700 | 1 | _aVoronin, Eugene | |
| 700 | 1 | _aPulido, Federico | |
| 700 | 1 | _aFelizarta, Franco | |
| 700 | 1 | _aAlmond, Steve | |
| 700 | 1 | _aSt Clair, Marty | |
| 700 | 1 | _aFlack, Nancy | |
| 700 | 1 | _aMin, Sherene | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 27 _gno. 11 _gp. 1771-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/QAD.0b013e3283612419 _zAvailable from publisher's website |
| 999 |
_c22872880 _d22872880 |
||